EUVIMEDEUVIMED entdecken
Crossref

Revisiting liver metabolism through acetyl-CoA carboxylase inhibition

Armando Jesús Pérez-Díaz, María Ángeles Núñez-Sánchez, Bruno Ramos-Molina

Trends in Endocrinology & Metabolism · 2024

DOI: 10.1016/j.tem.2024.04.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Endocrinology & Metabolism, 2024. Verfasst von Armando Jesús Pérez-Díaz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science, University "ROMA TRE", 00146, Rome, Italy. Hauptthemen laut MEDLINE: Acetyl-CoA Carboxylase, Liver. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 12 Literaturangaben. Gefördert von: European Regional Development Fund, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver-targeted acetyl-coenzyme A (CoA) carboxylase (ACC) inhibitors in metabolic dysfunction-associated steatotic liver disease (MASLD) trials reveal notable secondary effects: hypertriglyceridemia and altered glucose metabolism, paradoxically with reduced hepatic steatosis. In their study, Deja et al. explored how hepatic ACC influences metabolism using different pharmacological and genetic methods, coupled with targeted metabolomics and stable isotope-based tracing techniques.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acetyl-CoA CarboxylaseLiverAnimalsHumansEnzyme InhibitorsFatty Liver

Stichwörter der Autor:innen

acetyl-CoA carboxylaseautophagylipogenesisliver metabolismmalonyl-CoA

Substanzen

Acetyl-CoA CarboxylaseEnzyme Inhibitors

Autor:innen und Institutionen

  • Department of Science, University "ROMA TRE", 00146, Rome, Italy.
  • Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain. Electronic address: mariaa.nunez@imib.es.
  • Obesity, Diabetes and Metabolism Laboratory, Biomedical Research Institute of Murcia (IMIB), 30120 Murcia, Spain. Electronic address: bruno.ramos@imib.es.

Förderung

  • European Regional Development Fund
  • Instituto de Salud Carlos III

Zitieren

APA

Pérez-Díaz, A. J., Núñez-Sánchez, M. Á., & Ramos-Molina, B. (2024). Revisiting liver metabolism through acetyl-CoA carboxylase inhibition. Trends in Endocrinology & Metabolism. https://doi.org/10.1016/j.tem.2024.04.010

Vancouver

Pérez-Díaz AJ, Núñez-Sánchez MÁ, Ramos-Molina B. Revisiting liver metabolism through acetyl-CoA carboxylase inhibition. Trends in Endocrinology & Metabolism. 2024. doi:10.1016/j.tem.2024.04.010

BibTeX
@article{PrezDaz2024,
  author = {Pérez-Díaz, Armando Jesús and Núñez-Sánchez, María Ángeles and Ramos-Molina, Bruno},
  title = {Revisiting liver metabolism through acetyl-CoA carboxylase inhibition},
  journal = {Trends in Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1016/j.tem.2024.04.010}
}
Kostenlos starten →